University of Wisconsin, Madison
wisc.eduLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
1,166
Active
213
Phase 3
29
Total enrollment
2,560,650
Pipeline matrix
Showing 40 of 93 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Letermovir | — | — | — | — | 2 | ||
| Nicotine patch | — | — | — | — | 12 | ||
| Varenicline | — | — | — | — | — | 7 | |
| Paclitaxel | — | — | — | — | 4 | ||
| Fluticasone Propionate | — | — | — | — | — | 1 | |
| TAP Anesthesia | — | — | — | — | — | 1 | |
| Surgeon-Initiated Local Anesthetic | — | — | — | — | — | 1 | |
| Nicotine Pouches | — | — | — | — | — | 1 | |
| Mini Nicotine lozenges | — | — | — | — | — | 1 | |
| Envarsus XR | — | — | — | — | 2 | ||
| Pembrolizumab | — | — | 6 | ||||
| Nivolumab | — | — | — | — | — | 4 | |
| Bevacizumab | — | — | — | — | — | 4 | |
| Cetuximab | — | — | — | — | 4 | ||
| pTVG-HP | — | — | — | — | — | 3 | |
| pTVG-AR | — | — | — | — | 3 | ||
| Prazosin | — | — | — | — | — | 3 | |
| Saline | — | — | — | — | 2 | ||
| 18F-fluorofuranylnorprogesterone | — | — | — | — | — | 2 | |
| Prednisone | — | — | — | — | 3 | ||
| Tranexamic Acid | — | — | — | — | 2 | ||
| Anastrozole | — | — | — | — | 2 | ||
| Pegfilgrastim | — | — | — | — | 3 | ||
| Doxorubicin | — | — | — | — | — | 3 | |
| Vincristine | — | — | — | — | — | 2 | |
| Degarelix | — | — | — | — | 2 | ||
| Oxaliplatin | — | — | — | — | — | 2 | |
| GM-CSF | — | — | — | — | 2 | ||
| Panitumumab | — | — | — | — | — | 2 | |
| Celecoxib | — | — | — | — | — | 2 | |
| FAPI tracer | — | — | — | — | — | 1 | |
| CBD | — | — | — | — | — | 1 | |
| 18F-DCFPyL | — | — | — | — | — | 1 | |
| Rifampicin | — | — | — | — | — | 1 | |
| Isoniazid | — | — | — | — | — | 1 | |
| Pyrazinamide | — | — | — | — | — | 1 | |
| Ethambutol | — | — | — | — | — | 1 | |
| Cemiplimab | — | — | — | — | — | 1 | |
| Fianlimab | — | — | — | — | — | 1 | |
| FLT PET/CT | — | — | — | — | — | 1 |
53 more active programs hidden
Next readouts
- 2022-11-07
- 2023-12
- 2024-04-18
- 2024-11-24
- 2025-01-13
- 2025-12-09
- 2026-04-02
- 2026-07
- 2026-08
- 2026-08
Top conditions
- Breast Cancer33
- Prostate Cancer31
- Healthy27
- Obesity27
- Smoking26
- Smoking Cessation26
- Nicotine Dependence20
- Asthma19
Frequently asked questions about University of Wisconsin, Madison
- How many clinical trials does University of Wisconsin, Madison have on ClinicalTrials.gov?
- University of Wisconsin, Madison is listed as the lead sponsor on 1,166 clinical trials in ClinicalTrials.gov, 213 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Wisconsin, Madison's trials are in Phase 3?
- 29 of University of Wisconsin, Madison's trials are in Phase 3, spread across 93 active drug programs.
- What therapeutic areas does University of Wisconsin, Madison focus on?
- University of Wisconsin, Madison's most-studied conditions on ClinicalTrials.gov are Breast Cancer, Prostate Cancer, Healthy, Obesity, Smoking.
- When are University of Wisconsin, Madison's next clinical trial readouts?
- University of Wisconsin, Madison has 10 upcoming primary-completion readouts tracked here; the soonest is “pTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate Cancer”, expected around 2022-11-07.